Cite
MLA Citation
B. Glintborg et al.. “THU0123 Non-Medical Switch from Originator To Biosimilar Infliximab among Patients with Inflammatory Rheumatic Disease – Impact on S-Infliximab and Antidrug-Antibodies. Results from The National Danish Rheumatologic Biobank and The Danbio Registry.” Annals of the rheumatic diseases, vol. 75, n.d., p. 224. http://access.bl.uk/ark:/81055/vdc_100135163914.0x000053